Announced Wed, 13 Aug · 18:24 IST

Unaudited Financial Results for quarter ended June 30, 2025

Revenue DeclinePat NegativeEbitda Margin CompressionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shree Hari Chemicals Export Ltd reported weak Q1 FY26 results with revenue from operations falling about 21% year-on-year to ₹2,431.60 lacs (₹3,087.30 lacs in Q1 FY25). The company swung from a small profit of ₹20.83 lacs in the year-ago quarter to a standalone net loss of ₹166.27 lacs, with the consolidated net loss slightly wider at ₹167.38 lacs. Total expenses of ₹2,673.97 lacs exceeded total income, driving the loss before tax to ₹(221.16) lacs versus a profit of ₹27.74 lacs a year ago. The auditor (Kailash Chand Jain & Co.) issued an unqualified (clean) limited review report with no qualifications or emphasis of matter. The company also confirmed NIL deviation in use of proceeds from its preferential issue (₹6.57 crores raised in Nov 2024 and Mar 2025).

Likely market impact

Shareholders face a sharp deterioration — the company moved from profit to loss on a double-digit revenue decline, signaling pressure on margins and demand. With a clean audit and no fund-use deviation, the concern is purely operational performance, which could weigh negatively on the stock in the near term.